Our Process

To get started, you will first have a consultation with one of our physicians to review your medical history and specific condition. If, after your consultation, the physician feels you are medically qualified and your condition is something we can potentially treat with our Adult Adipose Stem Cell  Protocols under our (IRB), we will schedule a time for you to visit our office located in Manhattan, Kansas. Our procedure is very safe and completed in one visit in most cases.
Simple Stem Cell Process

On the day of the procedure, your physicians will harvest a small amount of fat through a simple closed system lipoaspiration procedure. The harvested fat can come from several locations on your body. You and the Physician will determine the best location. This procedure is completed under a local anesthetic injection only. Unlike most major surgeries, you do not have to be put under with general anesthesia.

After the fat harvesting has been completed, you will be guided to a private room designed to allow you to relax. You can watch TV, listen to music, or just enjoy the quiet surroundings.

Once the adult stem cells are carefully processed from the fat and ready to be delivered, your physician will deploy them into your predetermined area of need. KRMC uses a new highly sophisticated Ultrasound Instrument (Terason uSmart 3200T) with Enhanced Needle Visualization (ENV) to ensure accurate delivery of the adult stem cells. www.terason.com/usmart3200t.  In most cases, we will also administer an (IV) drip of adult stem cells while you are being treated. The whole process takes less than four hours and involves very little to no pain.

When we are finished, we ask that you wear a provided medical waist band and bandage.  Your physician will then follow up with you in the days and weeks to come, to answer any questions you may have. Most people are back to work the next day with very little downtime.

Bone Marrow VS. Fat Derived Stem Cells – Is There A Controversy?

Whether your adult mesenchymal stem cells come from bone marrow or from fat probably does not make a difference in terms of clinical results. Although some centers claim that bone marrow derived cells are superior to fat derived cells, there is no evidence to substantiate that. The fact that there are many more studies on bone marrow cells does not prove clinical superiority but merely supports the obvious fact that fat derived cells are based on more recent discoveries and although evidence is accumulating, there are far fewer studies using these cells. It is important that one is not mislead by the word “bone” in bone marrow, possibly implying that, since this is an “orthopedic source,” it “might be better” for treating orthopedic conditions such as cartilage regeneration. In fact, the bone marrow is part of the reticulo-endothelial system and just happens to be found in the center of bone. All of these types of cells are equally primitive and have the potential to differentiate into mature functional tissues. For many disease types such as cardiac pathology, adipose derived cells appear to be showing superiority to bone marrow derived cells. This may be related to the well documented qualitative and quantitative attrition in bone marrow stem cell counts related to age and chronic illness (chronic disease causes bone marrow suppression). Such changes in the number of cells over time and the quality of cells dependent on health have not been seen in fat derived stem cells. Fat derived cells are a natural choice for our investigatory work considering their easy and rapid availability in extremely high numbers.